Stock listing
NASDAQ:GALT Galectin Therapeutics Inc. Stock
Home listing (NASDAQ) of Galectin Therapeutics Inc.
Follow Galectin Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:GALT
$3.32 USD -0.20 (-5.7%)
Close on Oct 30, 2026
- Day range
- $3.27 – $3.54 USDOct 30, 2026
- Volume
- 174,744 sharesOct 30, 2026
- Market cap
- $334.8M USDAt the close on Oct 30, 2026 · price × 100.8M shares outstanding
- 52-week range
- $2.03 – $7.13 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.08M USDMedian day 267,329 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GALT · Home | $3.32 USD | -0.20 (-5.7%) | 174,744 | $3.52 | $3.54 | $3.27 | $3.52 | Close on Oct 30, 2026 |
| Frankfurt:PHPN | €2.78 EUR | -0.02 (-0.7%) | — | €2.78 | €2.78 | €2.78 | €2.80 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:GALT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.32 | -0.20 | -5.7% | $3.52 | $3.54 | $3.27 | 174,744 | |
| $3.52 | -0.02 | -0.6% | $3.61 | $3.70 | $3.448 | 263,857 | |
| $3.54 | +0.16 | +4.7% | $3.37 | $3.56 | $3.27 | 141,090 | |
| $3.38 | +0.19 | +6.0% | $3.21 | $3.44 | $3.13 | 204,733 | |
| $3.19 | 0.00 | 0.0% | $3.20 | $3.255 | $3.11 | 164,390 | |
| $3.19 | -0.19 | -5.6% | $3.37 | $3.37 | $3.16 | 195,180 | |
| $3.38 | +0.01 | +0.3% | $3.34 | $3.50 | $3.27 | 161,500 | |
| $3.37 | -0.06 | -1.7% | $3.46 | $3.51 | $3.19 | 295,700 | |
| $3.43 | -0.07 | -2.0% | $3.51 | $3.62 | $3.41 | 200,200 | |
| $3.50 | -0.12 | -3.3% | $3.60 | $3.73 | $3.47 | 177,300 | |
| $3.62 | -0.09 | -2.4% | $3.71 | $3.81 | $3.61 | 169,400 | |
| $3.71 | +0.07 | +1.9% | $3.68 | $3.84 | $3.66 | 119,200 | |
| $3.64 | -0.05 | -1.4% | $3.66 | $3.86 | $3.61 | 409,000 | |
| $3.69 | -0.18 | -4.7% | $3.84 | $3.86 | $3.67 | 184,400 | |
| $3.87 | -0.07 | -1.8% | $3.92 | $4.01 | $3.84 | 99,700 | |
| $3.94 | +0.30 | +8.2% | $3.64 | $3.97 | $3.64 | 156,400 | |
| $3.64 | +0.02 | +0.6% | $3.62 | $3.69 | $3.51 | 270,800 | |
| $3.62 | -0.14 | -3.7% | $3.74 | $3.86 | $3.59 | 176,000 | |
| $3.76 | +0.03 | +0.8% | $3.75 | $3.79 | $3.57 | 277,900 | |
| $3.73 | -0.17 | -4.4% | $3.84 | $3.90 | $3.64 | 280,700 | |
| $3.90 | +0.14 | +3.7% | $3.82 | $3.94 | $3.75 | 220,100 | |
| $3.76 | -0.12 | -3.1% | $3.87 | $4.06 | $3.68 | 327,400 | |
| $3.88 | -0.03 | -0.8% | $3.90 | $4.05 | $3.82 | 198,100 | |
| $3.91 | -0.02 | -0.5% | $3.94 | $4.00 | $3.90 | 174,200 | |
| $3.93 | +0.03 | +0.8% | $3.86 | $3.99 | $3.80 | 168,800 | |
| $3.90 | -0.06 | -1.5% | $3.93 | $3.99 | $3.86 | 124,600 | |
| $3.96 | -0.09 | -2.2% | $4.00 | $4.04 | $3.78 | 153,300 | |
| $4.05 | -0.09 | -2.2% | $4.12 | $4.15 | $4.00 | 174,000 | |
| $4.14 | +0.18 | +4.5% | $4.05 | $4.24 | $4.05 | 258,000 | |
| $3.96 | +0.07 | +1.8% | $3.91 | $4.02 | $3.85 | 258,400 | |
| $3.89 | +0.18 | +4.9% | $3.71 | $3.92 | $3.68 | 1,065,800 | |
| $3.71 | +0.03 | +0.8% | $3.73 | $3.79 | $3.69 | 171,100 | |
| $3.68 | -0.05 | -1.3% | $3.71 | $3.80 | $3.61 | 274,000 | |
| $3.73 | -0.11 | -2.9% | $3.82 | $3.83 | $3.58 | 323,100 | |
| $3.84 | -0.07 | -1.8% | $3.95 | $4.09 | $3.82 | 337,900 | |
| $3.91 | +0.01 | +0.3% | $3.92 | $4.01 | $3.84 | 243,600 | |
| $3.90 | -0.15 | -3.7% | $4.00 | $4.05 | $3.84 | 253,000 | |
| $4.05 | -0.09 | -2.2% | $4.13 | $4.34 | $4.04 | 515,600 | |
| $4.14 | -0.47 | -10.2% | $4.60 | $4.65 | $4.10 | 393,300 | |
| $4.61 | +0.26 | +6.0% | $4.33 | $4.72 | $4.33 | 473,300 | |
| $4.35 | -0.13 | -2.9% | $4.50 | $4.60 | $4.22 | 244,100 | |
| $4.48 | +0.31 | +7.4% | $4.19 | $4.53 | $4.19 | 460,400 | |
| $4.17 | +0.22 | +5.6% | $3.91 | $4.39 | $3.91 | 479,500 | |
| $3.95 | -0.07 | -1.7% | $4.02 | $4.05 | $3.91 | 229,700 | |
| $4.02 | -0.12 | -2.9% | $4.14 | $4.20 | $3.95 | 271,100 | |
| $4.14 | -0.01 | -0.2% | $4.15 | $4.45 | $4.04 | 345,200 | |
| $4.15 | +0.16 | +4.0% | $3.95 | $4.21 | $3.92 | 291,100 | |
| $3.99 | +0.11 | +2.8% | $4.07 | $4.19 | $3.85 | 194,700 | |
| $3.88 | +0.20 | +5.4% | $3.68 | $3.97 | $3.58 | 227,600 | |
| $3.68 | +0.11 | +3.1% | $3.62 | $3.74 | $3.59 | 174,900 | |
| $3.57 | -0.10 | -2.7% | $3.67 | $3.75 | $3.44 | 313,000 | |
| $3.67 | +0.15 | +4.3% | $3.54 | $3.77 | $3.54 | 353,800 | |
| $3.52 | +0.01 | +0.3% | $3.47 | $3.55 | $3.33 | 317,900 | |
| $3.51 | +0.07 | +2.0% | $3.36 | $3.67 | $3.31 | 300,000 | |
| $3.44 | -0.09 | -2.5% | $3.50 | $3.55 | $3.20 | 388,200 | |
| $3.53 | +0.39 | +12.4% | $3.16 | $3.56 | $3.16 | 585,300 | |
| $3.14 | +0.01 | +0.3% | $3.12 | $3.26 | $3.12 | 231,500 | |
| $3.13 | +0.01 | +0.3% | $3.13 | $3.15 | $3.02 | 296,100 | |
| $3.12 | -0.33 | -9.6% | $3.39 | $3.40 | $3.09 | 371,000 | |
| $3.45 | +0.23 | +7.1% | $3.56 | $3.56 | $3.22 | 329,900 | |
| $3.22 | +0.13 | +4.2% | $3.13 | $3.25 | $3.07 | 511,000 | |
| $3.09 | +0.10 | +3.3% | $3.00 | $3.14 | $2.97 | 355,000 | |
| $2.99 | -0.04 | -1.3% | $2.96 | $3.12 | $2.72 | 843,800 | |
| $3.03 | +0.06 | +2.0% | $2.97 | $3.17 | $2.90 | 297,000 | |
| $2.97 | -0.26 | -8.0% | $3.26 | $3.34 | $2.96 | 387,700 | |
| $3.23 | -0.26 | -7.4% | $3.51 | $3.60 | $3.21 | 403,300 |
- Ticker
- NASDAQ:GALT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 51 slides
Latest news
Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
Oct 6, 2026
Closed $3.76 (+0.8%) on Oct 6, 2026
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $3.90 (-3.7%) on Sep 10, 2026
Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
Aug 14, 2026
Closed $3.44 (-2.5%) on Aug 14, 2026
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
Aug 4, 2026
Closed $2.99 (-1.3%) on Aug 4, 2026
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
Jun 23, 2026
Closed $3.12 (+11.4%) on Jun 23, 2026
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
May 27, 2026
Closed $2.70 (-3.2%) on May 27, 2026
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
May 15, 2026
Closed $2.17 (-7.7%) on May 15, 2026
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
May 11, 2026
Closed $2.21 (+5.2%) on May 11, 2026
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Mar 31, 2026
Closed $2.79 (+8.6%) on Mar 31, 2026
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
Mar 17, 2026
Closed $3.15 (-0.9%) on Mar 17, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 51 slides · July 2026
Technical Presentation (March 2026)
Technical · 33 slides · Mar 10, 2026
Investor Presentation (November 2025)
Investor deck · 54 slides · Nov 10, 2025
Investor Presentation (September 2025)
Investor deck · 40 slides · Sep 8, 2025
Galectin Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 114 in all · newest Oct 6, 2026 · oldest 2019
- Decks
- 51 decks · latest July 2026
Where Galectin Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GALT · Home listing · This page | NASDAQ | United States | USD |
| gettex:PHPN | gettex | Germany | EUR |
| LS Exchange:A1JV3R | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1JV3R | Lang & Schwarz | Germany | EUR |
| BOATS:GALT | BOATS | United States | USD |
| Dusseldorf:PHPN | Dusseldorf | Germany | EUR |
| Frankfurt:PHPN | Frankfurt | Germany | EUR |
| Munich:PHPN | Munich | Germany | EUR |
| Stuttgart:PHPN | Stuttgart | Germany | EUR |
| Tradegate:PHPN | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Galectin Therapeutics Inc.